Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
9 pending office actions • 9 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Kaohsiung Medical University has 9 pending office actions in the Biotechnology & Pharmaceuticals technology area. The portfolio shows significant diversification, as these actions are spread across the distinct art units and 9 distinct examiners. This equal number of pending actions and examiners suggests that no single individual or art unit has a dominant influence over the university's current prosecution pipeline. Such a broad distribution requires the university to manage many different examiner relationships simultaneously.
FAYE, MAMADOU is identified as the busiest examiner, although this individual is currently managing only 1 of the pending office actions. This distribution reflects a broad exposure to different examination styles across the USPTO. With the distinct art units involved, the university must address a wide range of technical standards and examination practices within the Biotechnology & Pharmaceuticals sector. This variety ensures that the pending office actions are subject to a diverse set of perspectives from the distinct examiners.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (33%) |
| §103 only | 2 (22%) |
| §112 only | 1 (11%) |
| Multi-statute (no §101) | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FAYE, MAMADOU | 1 | 78.5% | +6.5% |
| BARR, MARY EVANGELINE | 1 | 36.1% | +32.5% |
| WOLFF, ARIELLE R | 1 | 46.3% | +34.7% |
| RAMACHANDRAN, UMAMAHESWARI | 1 | 54.8% | +53.7% |
| HRANEK, KAREN AMANDA | 1 | 34.7% | +40.4% |
| JONES, CHRISTINE MICHELLE | 1 | 0.0% | +0.0% |
| COPPINS, JANET L | 1 | 72.6% | +26.1% |
| KALLAL, ROBERT JAMES | 1 | 59.4% | +31.2% |
| WRIGHT, SARAH C | 1 | 42.1% | +45.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17855736 | METHOD FOR ESTABLISHING ROBUST PREDICTION MODEL, PREDICTION SYSTEM, AND PROGNOSTIC SYSTEM FOR ALZHEIMER'S DISEASE | KALLAL, ROBERT JAMES | 15d |
| 18901161 | ARTIFICIAL INTELLIGENCE MODEL DEVICE OF ESTIMATING SURVIVAL RATES OF CRITICALLY ILL PATIENT | BARR, MARY EVANGELINE | — |
| 18746502 | Endotracheal tube position anomaly alerting device | WOLFF, ARIELLE R | — |
| 18715132 | Tellurium-containing compounds and the use of treating bacterial infections thereof | RAMACHANDRAN, UMAMAHESWARI | — |
| 18578721 | CLINICAL THERAPEUTIC DRUG PREDICTION AND RECOMMENDATION SYSTEM AND METHOD FOR EVALUATING EFFICACY OF SECOND-GENERATION HORMONE DRUG IN TREATMENT OF PROSTATE CANCER | HRANEK, KAREN AMANDA | — |
| 18506147 | Method for detection of single nucleotide variant | JONES, CHRISTINE MICHELLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17697935 | METHOD FOR PREPARING ZONAL LAYERED CHONDROCYTE SHEETS AND TREATING METHOD THEREOF | WRIGHT, SARAH C | 146d overdue |
| 17855736 | METHOD FOR ESTABLISHING ROBUST PREDICTION MODEL, PREDICTION SYSTEM, AND PROGNOSTIC SYSTEM FOR ALZHEIMER'S DISEASE | KALLAL, ROBERT JAMES | 15d |
| 18901161 | ARTIFICIAL INTELLIGENCE MODEL DEVICE OF ESTIMATING SURVIVAL RATES OF CRITICALLY ILL PATIENT | BARR, MARY EVANGELINE | — |
| 18746502 | Endotracheal tube position anomaly alerting device | WOLFF, ARIELLE R | — |
| 18715132 | Tellurium-containing compounds and the use of treating bacterial infections thereof | RAMACHANDRAN, UMAMAHESWARI | — |
| 18578721 | CLINICAL THERAPEUTIC DRUG PREDICTION AND RECOMMENDATION SYSTEM AND METHOD FOR EVALUATING EFFICACY OF SECOND-GENERATION HORMONE DRUG IN TREATMENT OF PROSTATE CANCER | HRANEK, KAREN AMANDA | — |
| 18558364 | METHOD OF SYNTHESIZING DENDRIMERIC AMPHIPHILE | COPPINS, JANET L | — |
| Art Unit | Apps |
|---|---|
| 2884 | 1 |
| 3682 | 1 |
| 3785 | 1 |
| 1627 | 1 |
| 3684 | 1 |
| 1682 | 1 |
| 1628 | 1 |
| 1685 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19010213 | TEST PHANTOM FOR EVALUATING ELECTROMAGNETIC RADIATION IMAGES | FAYE, MAMADOU | 2884 | §103 | Non-Final OA | — | Pending | Jan 06, 2025 |
| 18901161 | ARTIFICIAL INTELLIGENCE MODEL DEVICE OF ESTIMATING SURVIVAL RATES OF CRITICALLY ILL PATIENT | BARR, MARY EVANGELINE | 3682 | §103§112 | Final Rejection | — | Pending | Sep 30, 2024 |
| 18746502 | Endotracheal tube position anomaly alerting device | WOLFF, ARIELLE R | 3785 | §101§102§103§112 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18715132 | Tellurium-containing compounds and the use of treating bacterial infections thereof | RAMACHANDRAN, UMAMAHESWARI | 1627 | §102§103§112 | Non-Final OA | — | Pending | May 31, 2024 |
| 18578721 | CLINICAL THERAPEUTIC DRUG PREDICTION AND RECOMMENDATION SYSTEM AND METHOD FOR EVALUATING EFFICACY OF SECOND-GENERATION HORMONE DRUG IN TREATMENT OF PROSTATE CANCER | HRANEK, KAREN AMANDA | 3684 | §101§112 | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18506147 | Method for detection of single nucleotide variant | JONES, CHRISTINE MICHELLE | 1682 | §103§112 | Final Rejection | — | Pending | Nov 10, 2023 |
| 18558364 | METHOD OF SYNTHESIZING DENDRIMERIC AMPHIPHILE | COPPINS, JANET L | 1628 | §112 | Non-Final OA | — | Pending | Oct 31, 2023 |
| 17855736 | METHOD FOR ESTABLISHING ROBUST PREDICTION MODEL, PREDICTION SYSTEM, AND PROGNOSTIC SYSTEM FOR ALZHEIMER'S DISEASE | KALLAL, ROBERT JAMES | 1685 | §101§102§103 | Non-Final OA | 15d | Pending | Jun 30, 2022 |
| 17697935 | METHOD FOR PREPARING ZONAL LAYERED CHONDROCYTE SHEETS AND TREATING METHOD THEREOF | WRIGHT, SARAH C | 1619 | §103 | Non-Final OA | 146d overdue | Pending | Mar 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKaohsiung Medical University has 9 pending office actions as of October 2026, spread across 9 art units and 9 examiners.
Mamadou Faye has the most, with 1 of Kaohsiung Medical University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
